AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
APAC to see a reduction in imported surgical robotics
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Subscribe To Our Newsletter & Stay Updated
